Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04585750Phase 1/2Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Advanced Malignant NeoplasmAdvanced Solid TumorBreast Cancer+26 more
StudydirectorStart date: 2020-10-29

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerMetastatic CancerCarcinoma, Non-Small-Cell Lung+3 more
Similarity Score6%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Lung CancerBreast CancerColorectal Cancer+3 more
Similarity Score6%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Breast CancerProstate CancerColorectal Cancer+3 more
Similarity Score6%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Breast CancerColorectal CancerHER2-negative Breast Cancer+3 more

Worked with same sponsors:

Merck Sharp & Dohme LLC
Similarity Score6%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lung CancerProstate CancerBreast Cancer+2 more
Similarity Score5%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Lung CancerProstate CancerBreast Cancer+2 more
Similarity Score5%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Colorectal CancerAdvanced Malignant NeoplasmAdvanced Solid Tumor+2 more
Similarity Score5%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Lung CancerBreast CancerCarcinoma, Non-Small-Cell Lung+1 more
Similarity Score4%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung CancerNSCLC+1 more
Similarity Score4%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerAdvanced Solid TumorEndometrial Carcinoma+1 more

Worked with same sponsors:

Merck Sharp & Dohme LLC
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04585750Phase 1/2StudyDirector

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Advanced Malignant NeoplasmAdvanced Solid TumorBreast Cancer+26 more
Recruiting

All 1 trials loaded